ERIKA VOONG: Open Payments
NPI 1679233431 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,552 in 120 payments from 18 companies in 2025. Trend: 2023 $1,944 · 2024 $4,057 · 2025 $3,552
Food & beverage: $3,452Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $696 |
| GENZYME CORPORATION | 10 | $628 |
| Janssen Biotech, Inc. | 20 | $432 |
| Arcutis Biotherapeutics, Inc. | 16 | $332 |
| ABBVIE INC. | 12 | $281 |
| LEO Pharma Inc. | 7 | $175 |
| Amgen Inc. | 9 | $158 |
| Lilly USA, LLC | 5 | $134 |
| REVANCE THERAPEUTICS, INC. | 1 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
Products named: DUPIXENT, Bimzelx, TREMFYA, Zoryve, Otezla, RINVOQ, SKYRIZI, ADBRY.
Industry payments across NV — which companies pay providers there.
